Telix Pharmaceuticals Limited (TLPPF) Gross margin 2023–2025
Telix Pharmaceuticals Limited (TLPPF) gross margin by fiscal year — reported gross profit divided by reported revenue.
53.1%FY2025 · since FY2023: 62.9% → 53.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 53.1% | -12.0 pp |
| FY2024 | 65.1% | +2.2 pp |
| FY2023 | 62.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TLPPF financial trends
TLPPF RevenueTLPPF Net incomeTLPPF Net marginTLPPF Gross profitTLPPF Operating incomeTLPPF Operating marginTLPPF Operating cash flowTLPPF Free cash flowTLPPF Capital expendituresTLPPF Return on equityTLPPF Stock buybacksTLPPF Dividends paidTLPPF Total assetsTLPPF Total liabilitiesTLPPF Shareholders’ equityTLPPF overview →